Daguplo, Julio S.

HRN: 27-03-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2025
CEFTRIAXONE 1G (VIAL)
04/24/2025
04/30/2025
IVTT
2g
OD
TBI; Lacerated Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: